Michael Woudenberg
2024
In 2024, Michael Woudenberg earned a total compensation of $349.2K as Chief Operating Officer at InMed Pharmaceuticals, a 17% increase compared to previous year.
Compensation breakdown
| Bonus | $54,400 |
|---|---|
| Option Awards | $22,800 |
| Salary | $272,000 |
| Total | $349,200 |
Woudenberg received $272K in salary, accounting for 78% of the total pay in 2024.
Woudenberg also received $54.4K in bonus and $22.8K in option awards.
Rankings
In 2024, Michael Woudenberg's compensation ranked 155th out of 207 executives tracked by ExecPay. In other words, Woudenberg earned more than 25.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 155 out of 207 | 25th |
Division Manufacturing | 62 out of 89 | 30th |
Major group Chemicals And Allied Products | 26 out of 36 | 28th |
Industry group Drugs | 26 out of 33 | 21st |
Industry Pharmaceutical Preparations | 24 out of 30 | 20th |
Source: SEC filing on October 28, 2024.
Woudenberg's colleagues
We found five more compensation records of executives working with Michael Woudenberg at InMed Pharmaceuticals in 2024.
2024
Eric Adams
InMed Pharmaceuticals
Chief Executive Officer
2024
Eric Hsu
InMed Pharmaceuticals
Senior Vice President, Preclinical Research & Development
2024
Alexandra Mancini
InMed Pharmaceuticals
Senior Vice President, Clinical & Regulatory Affairs
2024
Netta Jagpal
InMed Pharmaceuticals
Chief Financial Officer
2024
Jonathan Tegge
InMed Pharmaceuticals